{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:44:16Z","timestamp":1788867856690,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004896","name":"Eisai Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["R01AG063913"],"award-info":[{"award-number":["R01AG063913"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s40120-025-00746-6","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T22:37:20Z","timestamp":1746484640000},"page":"1287-1298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Feasibility of Identifying Acute Nontraumatic Intracerebral Hemorrhage Events Using Diagnostic Coding Among Veterans with Mild Cognitive Impairment or Alzheimer\u2019s Dementia"],"prefix":"10.1007","volume":"14","author":[{"given":"Dan","family":"Berlowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Reisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa Carlota Andreu","family":"Arasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brant","family":"Mittler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Abbas","family":"Tahami Monfared","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Irizarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanwu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7463-3295","authenticated-orcid":false,"given":"Weiming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"746_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14283\/jpad.2022.30","volume":"9","author":"S Budd Haeberlein","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F, et al. Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2022;9:197\u2013210.","journal-title":"J Prev Alzheimers Dis"},{"key":"746_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"746_CR3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.14283\/jpad.2022.34","volume":"9","author":"JR Sims","year":"2022","unstructured":"Sims JR, Zimmer JA, Evans CD, et al. Donanemab in early symptomatic Alzheimer update. J Prev Alzheimers Dis. 2022;9:221\u201330.","journal-title":"J Prev Alzheimers Dis."},{"key":"746_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"J Cummings","year":"2023","unstructured":"Cummings J, Apostolova L, Rabinovici GD, et al. Lecanemab: appropriate use Disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330:512\u201327.","journal-title":"JAMA"},{"key":"746_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.14283\/jpad.2023.30","volume":"10","author":"J Cummings","year":"2023","unstructured":"Cummings J, Rabinovici GD, Atri A, et al. Aducanumab: appropriate use recommendations recommendations. J Prev Alzheimers Dis. 2023;10:362\u201377.","journal-title":"J Prev Alzheimers Dis"},{"key":"746_CR6","doi-asserted-by":"publisher","DOI":"10.1148\/rg.230009","volume":"43","author":"A Agarwal","year":"2023","unstructured":"Agarwal A, Gupta V, Brahmbhatt P, et al. Amyloid-related imaging abnormalities in Alzheimer disease treated with anti-amyloid-\u03b2 therapy. Radiographics. 2023;43: e230009. https:\/\/doi.org\/10.1148\/rg.230009.","journal-title":"Radiographics"},{"key":"746_CR7","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1093\/brain\/awad188","volume":"146","author":"H Hampel","year":"2023","unstructured":"Hampel H, Elhage A, Cho M, Apostolova LG, Nicoll JAR, Atri A. Amyloid-related imaging abnormalities (ARIA): radiological, biological, and clinical characteristics. Brain. 2023;146:4414\u201324.","journal-title":"Brain"},{"key":"746_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/WNL.0000000000008924","volume":"94","author":"R Waziry","year":"2020","unstructured":"Waziry R, Chibnik LB, Bos D, Ikram MK, Hofman A. Risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease: a synthesis of the literature. Neurology. 2020;94:265\u201372.","journal-title":"Neurology"},{"key":"746_CR9","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1212\/WNL.0000000000004797","volume":"90","author":"M Pasi","year":"2018","unstructured":"Pasi M, Charidimou A, Boulouis G, Auriel E, Ayres A, Schwab KM, Goldstein JN, Rosand J, Viswanathan A, Pantoni L, Greenberg SM, Gurol ME. Mixed-location cerebral hemorrhage\/microbleeds: underlying microangiopathy and recurrence risk. Neurology. 2018;90:e119\u201326. https:\/\/doi.org\/10.1212\/WNL.0000000000004797.","journal-title":"Neurology"},{"key":"746_CR10","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJM200105103441907","volume":"344","author":"AI Qureshi","year":"2001","unstructured":"Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450\u201360.","journal-title":"N Engl J Med"},{"key":"746_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/alz.12366","volume":"18","author":"L J\u00e4kel","year":"2022","unstructured":"J\u00e4kel L, De Kort AM, Klijn CJM, Schreuder FHBM, Verbeek MM. Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis. Alzheimers Dement. 2022;18:10\u201328. https:\/\/doi.org\/10.1002\/alz.12366.","journal-title":"Alzheimers Dement"},{"key":"746_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1056\/NEJM200001273420403","volume":"342","author":"HC O'Donnell","year":"2000","unstructured":"O\u2019Donnell HC, Rosand J, Knudsen KA, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med. 2000;342:240\u20135.","journal-title":"N Engl J Med"},{"key":"746_CR13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.emc.2012.06.003","volume":"30","author":"JA Caceres","year":"2012","unstructured":"Caceres JA, Goldstein JN. Intracranial hemorrhage. Emerg Med Clin North Am. 2012;30:771\u201394. https:\/\/doi.org\/10.1016\/j.emc.2012.06.003.","journal-title":"Emerg Med Clin North Am"},{"key":"746_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/CLEP.S288518","volume":"13","author":"MT Hsieh","year":"2021","unstructured":"Hsieh MT, Huang KC, Hsieh CY, Tsai TT, Chen LC, Sung SF. Validation of ICD-10-CM diagnosis codes for identification of patients with acute hemorrhagic stroke in a national health insurance claims database. Clin Epidemiol. 2021;13:43\u201351.","journal-title":"Clin Epidemiol"},{"key":"746_CR15","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2147\/CLEP.S167576","volume":"10","author":"SM Hald","year":"2018","unstructured":"Hald SM, Kring Sloth C, Hey SM, et al. Intracerebral hemorrhage: positive predictive value of diagnosis codes in two nationwide Danish registries. Clin Epidemiol. 2018;10:941\u20138.","journal-title":"Clin Epidemiol"},{"key":"746_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135834","volume":"10","author":"N McCormick","year":"2015","unstructured":"McCormick N, Bhole V, Lacaille D, Avina-Zubieta JA. Validity of diagnostic codes for acute stroke in administrative databases: a systematic review. PLoS One. 2015;10: e0135834. https:\/\/doi.org\/10.1371\/journal.pone.0135834.","journal-title":"PLoS One"},{"key":"746_CR17","first-page":"114","volume":"109","author":"MA Kirkman","year":"2009","unstructured":"Kirkman MA, Mahattanakul W, Gregson BA, Mendelow AD. The accuracy of hospital discharge coding for hemorrhagic stroke. Acta Neurol Belg. 2009;109:114\u20139.","journal-title":"Acta Neurol Belg"},{"key":"746_CR18","unstructured":"US Department of Veterans Affairs. Veterans Health Administration. 2023. https:\/\/www.va.gov\/health\/aboutvha.asp#:~:text=The%20Veterans%20Health%20Administration%20(VHA,the%20VA%20health%20care%20program. Accessed 12 September 2024."},{"key":"746_CR19","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s40120-023-00540-2","volume":"12","author":"BJ Aguilar","year":"2023","unstructured":"Aguilar BJ, Miller D, Jasuja G. Rule-based identification of individuals with mild cognitive impairment or Alzheimer\u2019s disease using clinical notes from the United States Veterans Affairs Healthcare System. Neurol Ther. 2023;12:2067\u201378.","journal-title":"Neurol Ther"},{"key":"746_CR20","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/jcbfm.2015.25","volume":"35","author":"E Mart\u00ednez-Lizana","year":"2015","unstructured":"Mart\u00ednez-Lizana E, Carmona-Iragui M, Alcolea D, et al. Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunami. J Cereb Blood Flow Metab. 2015;35:710\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"key":"746_CR21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/14737175.2019.1623671","volume":"19","author":"IC Hostettler","year":"2019","unstructured":"Hostettler IC, Seiffge DJ, Werring DJ. Intracerebral hemorrhage: an update on diagnosis and treatment. Expert Rev Neurother. 2019;19:679\u201394.","journal-title":"Expert Rev Neurother"},{"key":"746_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/WCO.0000000000000510","volume":"31","author":"MJH Wermer","year":"2018","unstructured":"Wermer MJH, Greenberg SM. The growing clinical spectrum of cerebral amyloid angiopathy. Curr Opin Neurol. 2018;31:28\u201335.","journal-title":"Curr Opin Neurol"},{"key":"746_CR23","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1212\/WNL.0000000000004259","volume":"89","author":"A Charidimou","year":"2017","unstructured":"Charidimou A, Imaizumi T, Moulin S, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a meta-analysis. Neurology. 2017;89:820\u20139.","journal-title":"Neurology"},{"key":"746_CR24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676\u201382.","journal-title":"Am J Epidemiol"},{"key":"746_CR25","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2019.2000","volume":"321","author":"GD Rabinovici","year":"2019","unstructured":"Rabinovici GD, Gatsonis C, Apgar C, et al. Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or dementia. JAMA. 2019;321:1286\u201394.","journal-title":"JAMA"},{"key":"746_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ana.23931","volume":"74","author":"RC Petersen","year":"2013","unstructured":"Petersen RC, Aisen P, Boeve BF, et al. Mild cognitive impairment due to Alzheimer disease in the community. Ann Neurol. 2013;74:199\u2013208.","journal-title":"Ann Neurol"},{"key":"746_CR27","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/alz.13809","volume":"20","author":"Alzheimer's disease facts and figures","year":"2024","unstructured":"Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2024;20:3708\u2013821.","journal-title":"Alzheimers Dement"},{"key":"746_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","volume":"134","author":"A Kapasi","year":"2017","unstructured":"Kapasi A, DeCarli C, Schneider JA. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol. 2017;134:171\u201386.","journal-title":"Acta Neuropathol"},{"key":"746_CR29","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jalz.2016.09.015","volume":"13","author":"WD Brenowitz","year":"2017","unstructured":"Brenowitz WD, Hubbard RA, Keene CD, Hawes SE, Longstreth WT Jr, Woltjer RL, Kukull WA. Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample. Alzheimers Dement. 2017;13:654\u201362.","journal-title":"Alzheimers Dement"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-025-00746-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T13:22:13Z","timestamp":1757164933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-025-00746-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["746"],"URL":"https:\/\/doi.org\/10.1007\/s40120-025-00746-6","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Amir Abbas Tahami Monfared, Michael Irizarry, Raymond Zhang, and Quanwu Zhang are employees of Eisai Inc. The other authors, Dan Berlowitz, Ying Wang, Joel Reisman, Donald Miller, Peter J Morin, Vanesa Carlota Andreu Arasa, Brant Mittler, and Weiming Xia declare no conflict of interest. The funders had no decisional role in the study design, data collection and analysis, or decision to present or publish the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the institutional review board of Bedford VA Hospital. The data was not identifiable. This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}